当前位置:首页 - 行情中心 - 罗欣药业(002793) - 财务分析 - 现金流量表

罗欣药业

(002793)

  

流通市值:49.52亿  总市值:49.59亿
流通股本:10.86亿   总股本:10.88亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,944,586,987.871,298,083,745.71666,158,367.113,668,556,745.68
收到的税费返还115,475,491.0295,111,225.72-4,687,412.64
收到其他与经营活动有关的现金131,741,392.6894,352,289.7665,209,714.51697,821,022.51
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,191,803,871.571,487,547,261.19731,368,081.624,371,065,180.83
购买商品、接受劳务支付的现金514,546,301.02318,685,489.84237,135,832.911,777,844,240.16
支付给职工以及为职工支付的现金500,408,359.45372,033,598.35155,141,742.55920,172,150.74
支付的各项税费141,129,257.5293,891,385.8641,804,371.8585,898,975.12
支付其他与经营活动有关的现金718,774,647.06570,092,013.41270,435,495.632,026,276,717.7
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,874,858,565.051,354,702,487.46704,517,442.895,310,192,083.72
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额316,945,306.52132,844,773.7326,850,638.73-939,126,902.89
二、投资活动产生的现金流量:
收回投资收到的现金37,458,20027,458,200627,658,412.96142,275,671.23
取得投资收益收到的现金86,507,275.685,090,888.9658,524.763,803,492.31
处置固定资产、无形资产和其他长期资产收回的现金净额3,416,6813,386,681214,071.353,070,308.36
收到的其他与投资活动有关的现金1,096,085,845.76824,429,472.432,475,779.5967,415,687.95
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,223,468,002.36940,365,242.39630,406,788.66216,565,159.85
购建固定资产、无形资产和其他长期资产支付的现金160,021,835.9267,991,818.2841,446,415.45194,819,597.16
投资支付的现金21,000,00012,000,0004,000,00076,927,878.26
取得子公司及其他营业单位支付的现金---1,928,114.29
支付其他与投资活动有关的现金---62,071,340.78
投资活动现金流出的平衡项目0000
投资活动现金流出小计181,021,835.9279,991,818.2845,446,415.45335,746,930.49
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额1,042,446,166.44860,373,424.11584,960,373.21-119,181,770.64
三、筹资活动产生的现金流量:
吸收投资收到的现金26,477,90025,187,20010,300,00082,428,096.75
其中:子公司吸收少数股东投资收到的现金26,477,90025,187,20010,300,00082,428,096.75
取得借款收到的现金918,857,548.57468,350,364.78238,157,915.522,097,960,000
收到其他与筹资活动有关的现金454,760,086.37298,090,086.37-982,478,439.59
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,400,095,534.94791,627,651.15248,457,915.523,162,866,536.34
偿还债务支付的现金2,218,553,342.511,248,994,987.681,015,421,607.942,246,627,029.63
分配股利、利润或偿付利息支付的现金56,849,841.8145,523,091.9123,911,152.11138,264,707.48
支付其他与筹资活动有关的现金589,165,260.48392,437,065.867,060,000392,996,648.06
筹资活动现金流出平衡项目0000
筹资活动现金流出小计2,864,568,444.81,686,955,145.451,046,392,760.052,777,888,385.17
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,464,472,909.86-895,327,494.3-797,934,844.53384,978,151.17
四、汇率变动对现金及现金等价物的影响5,127,844.96,653,608.67-5,232,879.814,098,776.45
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-99,953,592104,544,312.21-191,356,712.39-659,231,745.91
加:期初现金及现金等价物余额834,355,018.6834,355,018.6834,355,018.61,493,586,764.51
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额734,401,426.6938,899,330.81642,998,306.21834,355,018.6
补充资料:
净利润--161,694,808.59--1,257,985,592.93
资产减值准备-9,917,143.51-92,544,642.51
固定资产和投资性房地产折旧-92,419,842.7-180,412,529.72
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-92,419,842.7-180,412,529.72
无形资产摊销-13,573,591.38-24,918,681.14
长期待摊费用摊销-3,901,699.76-42,059,106.56
处置固定资产、无形资产和其他长期资产的损失--1,925,831.71--1,736,320.12
固定资产报废损失-748,386.75-546,186.21
公允价值变动损失----2,012,862.44
财务费用-46,491,016.67-131,548,350.67
投资损失--3,597,351.08--166,292,591.7
递延所得税-11,709,737.85--265,076,138.54
其中:递延所得税资产减少-13,565,268.63--265,076,138.54
递延所得税负债增加--1,855,530.78--
存货的减少-105,649,833.12--52,036,042.92
经营性应收项目的减少-323,405,194.9-689,643,693.71
经营性应付项目的增加--316,561,365.4--381,635,338.27
现金的期末余额-938,899,330.81-834,355,018.6
减:现金的期初余额-834,355,018.6-1,493,586,764.51
公告日期2023-10-282023-08-292023-04-282023-04-28
审计意见(境内)标准无保留意见
TOP↑